Related Experiment Video
Updated: Dec 10, 2025
08:42
Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
11.5K
Biliary Dyskinesia: Fact or fiction?
M Coluccio1, A J Claffey1, D H Rothstein2
1University at Buffalo Jacobs School of Medicine and Biomedical Sciences, 818 Ellicott St, Buffalo, New York, 14203, USA.
Seminars in Pediatric Surgery
|August 31, 2020
Summary
Biliary dyskinesia is a common reason for pediatric gallbladder removal, but surgery doesn't always help. This review covers diagnosis and treatment for abnormal gallbladder emptying in children.
Area of Science:
- Pediatric surgery
- Gastroenterology
- Nuclear medicine
Background:
- Cholecystectomy is increasingly performed in pediatric patients.
- Biliary dyskinesia is now the primary indication for pediatric cholecystectomy in the USA, surpassing gallstones.
- Not all pediatric patients with abnormal gallbladder emptying benefit from cholecystectomy.
Purpose of the Study:
- To review current data on the presentation, diagnosis, and treatment of pediatric patients with abnormal gallbladder emptying.
- To provide insights into the management of biliary dyskinesia in children.
Main Methods:
- Literature review of studies on pediatric gallbladder emptying disorders.
- Analysis of data regarding presentation, diagnostic workup, and treatment outcomes.
- Focus on nuclear medicine scan findings for gallbladder ejection fraction.
Main Results:
- Biliary dyskinesia is the leading indication for cholecystectomy in US pediatric patients.
- Abnormal gallbladder emptying rates (low or high) do not guarantee surgical success.
- Variability exists in patient response to cholecystectomy for this condition.
Conclusions:
- Further research is needed to optimize the management of pediatric biliary dyskinesia.
- Careful patient selection and understanding of treatment outcomes are crucial.
- This review synthesizes current knowledge to guide clinical practice.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
668
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
668
01:16Hepatic Drug Excretion: Influencing Factors
422
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
422
01:26Diseases of the Liver and Gallbladder
1.7K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.7K
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
103
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
103
01:20Gastrointestinal Motility Disorders
904
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
904
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
995
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
995